Article

You have free access to this content

The Staging of Cancer: A Retrospective and Prospective Appraisal†

  1. Dr. Frederick L. Greene MD1,
  2. Dr. Leslie H. Sobin MD2

Article first published online: 31 DEC 2008

DOI: 10.3322/CA.2008.0001

Issue

CA: A Cancer Journal for Clinicians

CA: A Cancer Journal for Clinicians

Volume 58, Issue 3, pages 180–190, May/June 2008

Additional Information

How to Cite

Greene, F. L. and Sobin, L. H. (2008), The Staging of Cancer: A Retrospective and Prospective Appraisal. CA: A Cancer Journal for Clinicians, 58: 180–190. doi: 10.3322/CA.2008.0001

Author Information

  1. 1

    Greene is Chairman, Department of Surgery, Carolinas Medical Center, Charlotte, NC

  2. 2

    Sobin is Chief, Gastrointestinal Pathology, Armed Forces Institute of Pathology, Washington, DC

  1. †

    Published online through CA First Look at http://CAonline.AmCancer.Soc.org.

Publication History

  1. Issue published online: 31 DEC 2008
  2. Article first published online: 31 DEC 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (384K)

References

  • 1
    Samowitz WS, Curtin K, Ma KN, et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 2001; 10: 917–923.
  • 2
    Dukes CE. The classification of cancer of the rectum. J Pathol Bacterial 1932; 35: 323–332.
    Direct Link:
  • 3
    Denoix PF. Nomenclature classification des cancers [in French]. Bull Inst Nat Hyg (Paris) 1952; 7: 743–748.
  • 4
    UICC Committee on Clinical Stage Classification and Applied Statistics. Clinical Stage Classification and Presentation of Results, Malignant Tumours of the Breast and Larynx. Paris, France: International Union Against Cancer; 1958.
  • 5
    International Union Against Cancer. TNM Classification of Malignant Tumours. Geneva, Switzerland: International Union Against Cancer; 1968.
  • 6
    International Union Against Cancer. TNM Classification of Malignant Tumours. 2nd ed. Geneva, Switzerland: International Union Against Cancer; 1974.
  • 7
    HarmerMH, ed. TNM Classification of Malignant Tumours. 3rd ed. Geneva, Switzerland: International Union Against Cancer; 1978. Enlarged and revised 1982.
  • 8
    Hutter RV. At last—worldwide agreement on the staging of cancer. Arch Surg 1987; 122: 1235–1239.
  • 9
    Wittekind C, Greene FL, Hutter RV, et al. TNM Atlas: Illustrated Guide to the TNM Classification of Malignant Tumors. 5th ed. Hoboken, NJ: John Wiley & Sons; 2005.
  • 10
    Greene FL, Compton CC, Fritz AG, et al. AJCC Cancer Staging Atlas. New York, NY: Springer, Inc.; 2006.
  • 11
    Hermanek P, Henson DE, Hutter RV, Sobin LH. International Union Against Cancer (UICC): TNM Supplement 1993. A Commentary on Uniform Use. New York, NY: Springer-Verlag; 1993.
  • 12
    Hermanek P, Gospodarowicz MK, Henson DE, et al. International Union Against Cancer (UICC): Prognostic Factors in Cancer. New York, NY: Springer-Verlag; 1995.
  • 13
    Gospodarowicz MK, Henson DE, Hutter RV, et al. Prognostic Factors in Cancer. 2nd ed. New York, NY: Wiley-Liss; 2001.
  • 14
    Gospodarowicz MK, O'Sullivan B, Sobin LH. Prognostic Factors in Cancer. 3rd ed. New York, NY: Wiley; 2006.
  • 15
    Sobin LH, Wittekind C. International Union Against Cancer (UICC) TNM Classification Of Malignant Tumors. 6th ed. New York, NY: Wiley-Liss; 2002.
  • 16
    Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.
  • 17
    TNM Online. Available at: http://www3.interscience.wiley.com/cgi-bin/mrwhome/104554799/HOME. Accessed November 6, 2007.
  • 18
    Gospodarowicz MK, Miller D, Groome PA, et al. The process for continuous improvement of the TNM classification. Cancer 2004; 100: 1–5.
    Direct Link:
  • 19
    Harrington L, Bristow RG, Hill RP, Tannock IF. Introduction to cancer biology, in TannockIF, HillRP, BristowRG, HarringtonL (eds). The Basic Science of Oncology. 4th ed. New York, NY: McGraw Hill; 2005: 1–3.
  • 20
    Fleming ID, Cooper JS, Henson DE, et al. AJCC Cancer Staging Manual. 5th ed. Philadelphia, PA: Lippincott-Raven; 1997.
  • 21
    Sobin LH, Wittekind C. TNM Classification of Malignant Tumours. 5th ed. New York, NY: Wiley-Liss; 1997.
  • 22
    Sugg SL, Ferguson DJ, Posner MC, Heimann R. Should internal mammary nodes be sampled in the sentinel lymph node era? Ann Surg Oncol 2000; 7: 188–192.
  • 23
    Ross MI. Early-stage melanoma: staging criteria and prognostic modeling. Clin Cancer Res 2006; 12: 2312s–2319s.
  • 24
    Hermanek P, Hutter RV, Sobin LH, Wittekind C. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 1999; 86: 2668–2673.
  • 25
    Singletary E, Greene FL, Sobin LH. Classification of isolated tumor cells: Clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer 2003; 98: 2740–2741.
    Direct Link:
  • 26
    Scheri RP, Essner R, Turner RR, et al. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann Surg Oncol 2007; 14: 2861–2866.
  • 27
    Dell'Orto P, Biasi MO, Del Curto B, et al. Assessing the status of axillary sentinel lymph nodes of breast carcinoma patients by a real-time quantitative RT-PCR assay for mammaglobin 1 mRNA. Breast Cancer Res Treat 2006; 98: 185–190.
  • 28
    Greene FL, Stewart AK, Norton HJ. A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Ann Surg 2002; 236: 416–421.
  • 29
    André T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004; 350: 2343–2351.
  • 30
    Tsai HL, Lu CY, Hsieh JS, et al. The prognostic significance of total lymph node harvest in patients with T2-4N0M0 colorectal cancer. J Gastrointest Surg 2007; 11: 660–665.
  • 31
    Wong SL, Ji H, Hollenbeck BK, et al. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA 2007; 298: 2149–2154.
  • 32
    Fong Y, Coit DG, Woodruff JM, Brennan MF. Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg 1993; 217: 72–77.
  • 33
    Cunningham MP, Duda RB, Recant W, et al. Survival discriminants for differentiated thyroid cancer. Am J Surg 1990; 160: 344–347.
  • 34
    Hay ID. Management of patients with low-risk papillary thyroid carcinoma. Endocr Pract 2007; 13: 521–533.
  • 35
    Shah JP, Andersen PE. The impact of patterns of nodal metastasis on modifications of neck dissection. Ann Surg Oncol 1994; 1: 521–532.
  • 36
    Leung TW, Tang AM, Zee B, et al. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients. Cancer 2002; 94: 1760–1769.
    Direct Link:
  • 37
    Gospodarowicz MK, O'Sullivan B, Koh ES. Prognostic factors: principles and applications, in GospodarowiczMK, O'SullivanB, SobinLH (eds). Prognostic Factors in Cancer. 3rd ed. Hoboken, NJ: John Wiley & Sons; 2006: 23–38.
  • 38
    White RR, Kattan MW, Haney JC, et al. Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram. Ann Surg Oncol 2006; 13: 1485–1492.
  • 39
    Specht MC, Kattan MW, Gonen M, et al. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol 2005; 8: 654–659.
  • 40
    BeanWB, ed. Sir William Osler: Aphorisms from His Bedside Teachings and Writings. Collected by Robert Bennett Bean, M.D. 3rd ed. Springfield, IL: Charles C. Thomas Co., 1968.
View Full Article (HTML) Get PDF (384K)